search
Back to results

Very Preterm Children With Language Delay and Parent Intervention (EPILANG)

Primary Purpose

Preterm Birth, Language Development, Speech Therapy

Status
Terminated
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Parent-implemented intervention
Sponsored by
Lille Catholic University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Preterm Birth focused on measuring prematurity, language, parent-implemented intervention, speech therapy, neurodevelopment

Eligibility Criteria

28 Months - 32 Months (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Child born at 24 to 31+6 weeks' gestation, whose parents did not refuse collection of follow-up data
  • Child aged 30 ± 2 months corrected age (CA) at inclusion
  • Child with language delay at 24 months CA, defined as the absence of word combination and/or expressive vocabulary of less than 30 words according to the short version of the French Mac Arthur Communication Developmental Inventories (CDI), whose language delay is confirmed at 30 months CA i.e. without word combination and/or an expressive vocabulary below the 10th percentile on the French CDI.
  • Child with a global Developmental Quotient (DQ) ≥ 55 at 30 months CA
  • Child whose parents accept participation in this study
  • Child with French health insurance coverage

Exclusion Criteria:

  • Child with neurological sequelae (delay or disability) and who is unable to walk without assistance at 24 months CA or who has a global DQ < 55 on the revised Brunet-Lézine (BLR) scale at 30 months CA.
  • Blindness
  • Deafness defined by the prescription of a hearing aid
  • Child with a chromosomal or other condition that could interfere with language development
  • Parents who do not speak French at all
  • Triplets

Sites / Locations

  • Centre Hospitalier
  • Centre Hospitalier Universitaire
  • Centre Hospitalier Universitaire
  • Hôpital Saint Vincent de Paul (GHICL)
  • Hôpital femme mère enfant
  • Centre Hospitalier Universitaire
  • Centre Hospitalier Universitaire
  • AP-HP Hôpital Antoine Béclère
  • Hôpital Necker
  • HôpitalCochin - Port Royal
  • Centre Hospitalier
  • Centre hospitalier Universitaire
  • Centre Hospitalier Universitaire
  • Centre Hospitalier Universitaire
  • Centre Hospitalier

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Parent-implemented language intervention

Control group

Arm Description

In the intervention group, the techniques and attitudes favouring use of oral language will be taught to the parents during 15 sessions with the parent(s) and child.

The control group will benefit from the actual routine care for children with language delay before the age of 3 years. In order to provide them the best routine care, the psychologist will provide some advice to the parents to enhance their child's language (e.g.: using life situations to talk with the child and encourage him/her to talk …).

Outcomes

Primary Outcome Measures

language score of the Developmental Neuropsychological assessment (NEPSY)
For the main outcome, mean language score on the NEPSY at the final visit, our primary endpoint, will be compared between groups using linear regression

Secondary Outcome Measures

Other scores of the NEPSY battery
To evaluate the child's neuropsychological functioning
Strengths and Difficulties Questionnaire
Parenting Stress Index (PSI) questionnaire

Full Information

First Posted
January 20, 2014
Last Updated
March 2, 2020
Sponsor
Lille Catholic University
Collaborators
Ministry of Health, France
search

1. Study Identification

Unique Protocol Identification Number
NCT02042235
Brief Title
Very Preterm Children With Language Delay and Parent Intervention
Acronym
EPILANG
Official Title
Parent-implemented Intervention for Very Preterm Children With Language Delay
Study Type
Interventional

2. Study Status

Record Verification Date
March 2020
Overall Recruitment Status
Terminated
Why Stopped
difficulted recruiting
Study Start Date
January 2014 (undefined)
Primary Completion Date
January 31, 2018 (Actual)
Study Completion Date
January 31, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Lille Catholic University
Collaborators
Ministry of Health, France

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
In studies of children born at term, language delay at the age of 2 years exhibits a spontaneously favourable course in 30 to 50% by the age of 3 years. In France, there is no recommendation for speech therapy before the age of 3 years. However, for term-born children, parent-implemented language interventions conducted during the third year of life have already shown a positive short-term effect on language skills. In these interventions, a skilled interventionist, generally a speech therapist, teaches parents how to use specific language strategies with their child. The investigators' hypothesis is that such parent-implemented interventions would be particularly appropriate at short and medium term for the improvement of linguistic performances in very preterm children, a population with a high prevalence of early language delay. Currently, there is an opportunity to partly nest an intervention trial in a national prospective population-based cohort of very preterm children, the EPIPAGE (Etude EPIdémiologique sur les Petits Ages GEstationnels) 2 cohort, which has included 5 000 babies born alive in France in 2011. This situation provides considerable methodological advantages.
Detailed Description
EPILANG is an open randomized controlled study, in which the final assessment of the children (endpoint) will be conducted by professionals blinded to the treatment group. Some eligible children will first be screened using the parental questionnaire at 24 months corrected age (CA) of the EPIPAGE 2 cohort. Children with language delay, defined as no words combination and/or less than 30 words from Mac Arthur CDI - short version, and free of exclusion criteria, will be invited to an inclusion visit at 30 months CA, if they are in an EPIPAGE 2 centre participating in the EPILANG trial. During the inclusion visit, inclusion criteria and the absence of exclusion criteria will be checked, data useful for the study will be collected, and the informed consent of the parents collected. The child will then be randomized either in the control or the intervention group if language delay is still present, defined by a score < 10th percentile at the Mac Arthur CDI. Twins, if both included, will be included in the same group, otherwise only the twin with a language delay will be randomized. The intervention is organized in 15 weekly one-hour sessions with the child, one or both parents and a speech therapist recruited and trained for the study. Maximum duration for the intervention will be 6 months per child, because some sessions can be missed or delayed. Parents' participation will be recorded. The usual "wait-and-see" attitude will be provided to the control group, together with basic advice to enhance the child's language at home. In both groups, audition will be checked by an otolaryngology specialist, following professional recommendations, and care will be provided in case of hearing deficit, if appropriate. At 3 years CA, a neuropsychological evaluation will be performed by trained psychologists for both groups, blinded for the allocation group. Behaviour will be evaluated with a validated parental questionnaire. The analysis will be according to intention to treat.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Preterm Birth, Language Development, Speech Therapy
Keywords
prematurity, language, parent-implemented intervention, speech therapy, neurodevelopment

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
67 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Parent-implemented language intervention
Arm Type
Experimental
Arm Description
In the intervention group, the techniques and attitudes favouring use of oral language will be taught to the parents during 15 sessions with the parent(s) and child.
Arm Title
Control group
Arm Type
No Intervention
Arm Description
The control group will benefit from the actual routine care for children with language delay before the age of 3 years. In order to provide them the best routine care, the psychologist will provide some advice to the parents to enhance their child's language (e.g.: using life situations to talk with the child and encourage him/her to talk …).
Intervention Type
Behavioral
Intervention Name(s)
Parent-implemented intervention
Intervention Description
In order to achieve the programme of parent-implemented language intervention, a detailed protocol for speech therapists recruited and trained for the present study has been established. The techniques and attitudes favouring use of oral language will be taught to the parents during 15 sessions with the parent(s) and child.
Primary Outcome Measure Information:
Title
language score of the Developmental Neuropsychological assessment (NEPSY)
Description
For the main outcome, mean language score on the NEPSY at the final visit, our primary endpoint, will be compared between groups using linear regression
Time Frame
at 36 months of corrected age
Secondary Outcome Measure Information:
Title
Other scores of the NEPSY battery
Description
To evaluate the child's neuropsychological functioning
Time Frame
at 36 months of corrected age
Title
Strengths and Difficulties Questionnaire
Time Frame
at 36 months of corrected age
Title
Parenting Stress Index (PSI) questionnaire
Time Frame
at 36 months of corrected age

10. Eligibility

Sex
All
Minimum Age & Unit of Time
28 Months
Maximum Age & Unit of Time
32 Months
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Child born at 24 to 31+6 weeks' gestation, whose parents did not refuse collection of follow-up data Child aged 30 ± 2 months corrected age (CA) at inclusion Child with language delay at 24 months CA, defined as the absence of word combination and/or expressive vocabulary of less than 30 words according to the short version of the French Mac Arthur Communication Developmental Inventories (CDI), whose language delay is confirmed at 30 months CA i.e. without word combination and/or an expressive vocabulary below the 10th percentile on the French CDI. Child with a global Developmental Quotient (DQ) ≥ 55 at 30 months CA Child whose parents accept participation in this study Child with French health insurance coverage Exclusion Criteria: Child with neurological sequelae (delay or disability) and who is unable to walk without assistance at 24 months CA or who has a global DQ < 55 on the revised Brunet-Lézine (BLR) scale at 30 months CA. Blindness Deafness defined by the prescription of a hearing aid Child with a chromosomal or other condition that could interfere with language development Parents who do not speak French at all Triplets
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Amélie Lansiaux, MD, PhD
Organizational Affiliation
Groupment des Hôpitaux de l'Institut Catholique de Lille
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Marie-Laure Charkaluk, MD, PhD
Organizational Affiliation
Hôpital Saint-Vincent-de-Paul, GHICL
Official's Role
Study Director
Facility Information:
Facility Name
Centre Hospitalier
City
Arras
ZIP/Postal Code
62000
Country
France
Facility Name
Centre Hospitalier Universitaire
City
Caen
ZIP/Postal Code
14000
Country
France
Facility Name
Centre Hospitalier Universitaire
City
Lille
ZIP/Postal Code
59000
Country
France
Facility Name
Hôpital Saint Vincent de Paul (GHICL)
City
Lille
ZIP/Postal Code
59000
Country
France
Facility Name
Hôpital femme mère enfant
City
Lyon
Country
France
Facility Name
Centre Hospitalier Universitaire
City
Marseille
Country
France
Facility Name
Centre Hospitalier Universitaire
City
Nantes
Country
France
Facility Name
AP-HP Hôpital Antoine Béclère
City
Paris
Country
France
Facility Name
Hôpital Necker
City
Paris
Country
France
Facility Name
HôpitalCochin - Port Royal
City
Paris
Country
France
Facility Name
Centre Hospitalier
City
Roubaix
ZIP/Postal Code
59100
Country
France
Facility Name
Centre hospitalier Universitaire
City
Rouen
ZIP/Postal Code
76000, 76100
Country
France
Facility Name
Centre Hospitalier Universitaire
City
Strasbourg
ZIP/Postal Code
67000
Country
France
Facility Name
Centre Hospitalier Universitaire
City
Tours
ZIP/Postal Code
37044
Country
France
Facility Name
Centre Hospitalier
City
Valenciennes
ZIP/Postal Code
59300
Country
France

12. IPD Sharing Statement

Learn more about this trial

Very Preterm Children With Language Delay and Parent Intervention

We'll reach out to this number within 24 hrs